Select Committee on Intergovernmental Organisations First Report


CHAPTER 4: ACCOUNTABILITY AND MANAGEMENT

177.  As will be seen from Table 1, the British Government invests substantial sums of taxpayers' money in IGOs in order to help curb the spread of infectious diseases, mainly in the developing world. We do not argue with the principle—or, indeed, the magnitude—of this investment, which serves the dual purpose, if successful, of relieving suffering in other parts of the world and at the same time keeping infectious diseases away from these shores. What concerns us is whether the investment is being managed in such a way as to maximise the effectiveness of the sums being spent and to ensure that its objectives are being achieved. Dawn Primarolo, Minister of State for Public Health at the Department of Health, endorsed this view. "We have to be accountable", she told us, "for the resources that have been spent and to explain why that happened" (Q 1148).

Bilateral Funding

178.  There was general agreement among those who gave evidence to us that a key underlying principle of UK Government aid in this field was that funding should go to governments in order to confer ownership of and support the implementation of national health plans rather than as donations earmarked for specific projects or purposes. In Dr Tyson's view, "money going to the government and being used effectively is not a great problem. In many, if not most, of DFID's African partners we have moved a large part of our resources into budget support. We have confidence that the policy environment is good, the practice is good, and the audits tell the same story" (Q 16). Others endorsed DFID's approach. Dr Bates, from the Royal College of Pathologists, told us that "DFID are one of the only organisations which are very far-thinking; they have pro-poor indicators on their programmes and programmes are not disease-specific. They are very much about strengthening systems … DFID is a very good example of the sort of innovative thinking that you can have around building systems and structures" (Q 309). Dr Billo, from the International Union against Tuberculosis and Lung Diseases, was making a similar point when he told us that "when you fund programmes in an isolated way, you may run the danger that they only look at their area of interest and not look in a lateral way. DFID has quite a good reputation in addressing that issue and not just funding programmes, they like to have a more holistic approach" (Q 1078).

TABLE 1
UK Government contributions to Intergovernmental Organisations involved in Infectious Disease Control
Organisation
DH
DFID
  
£m
£m
WHO
13.6
18.0
UNICEF
  
21.0
UNICEF (Children with AIDS) (2004)
  
44.0
UNDP
  
55.0
UNAIDS
  
10.0
UNFPA
  
20.0
UNFPA Global Programme to Enhance Reproductive Health
  
17.0*
UNFPA (RHCS in Fragile States)
  
5.0
Global Fund to Fight AIDS, TB and Malaria
  
110.0*
Roll-Back Malaria Partnership
  
5.0*
Stop TB Partnership
  
1.0*
UNITAID
  
38.0*
Medicines for Malaria Venture
  
2.0*
Drugs for Neglected Diseases
  
1.5*
Global Alliance for TB Drug Development
  
1.5*
WHO Tropical Disease Research
  
1.0
WHO Global Pandemic Influenza Action Programme
  
2.0
WHO Pledge to fight Avian and Pandemic Influenza
  
35.0
Other
  
1.0
Totals
51.6
350.0
Grand Total
  
401.6

See HM Government Evidence, Volume II, Page 16. Unless otherwise indicated, figures refer to 2007. Figures marked with an asterisk are annual averages of multi-annual commitments

179.  On the other hand, we have heard from many sources that, while alignment of health aid behind a recipient's national programme is the proper way to proceed, its ability to deliver results commensurate with the resources invested is crucially dependent on the existence of good in-country governance, meaning that there are systems in place both to manage donor funding efficiently and to preclude misappropriation of funds for other purposes. Dr Conlon, from the Royal College of Physicians, referred to non-evidence-based local management and to the need "to start educating people about responsibility for decision-making and the use of governance" (Q 315). Dr Lob-Levyt, from GAVI, told us:

    "In those countries where you can rely less on the government financial systems, we would be looking more to intermediaries to provide some of that function. For example, the World Bank would take on much more of a financial stewardship role at the country level and transfer the finances to the programmes until the capacity in those countries has been built to operate through national budgetary systems" (Q 802).

Indeed, Dr Tyson had already suggested to us[27] that DFID followed such a case-by-case approach.

180.  Gillian Merron, Parliamentary Under-Secretary of State at DFID, described to us her Department's arrangements for oversight of bilateral funding. "We identify with our partner governments", she told us, "what we expect for that [funding] and we monitor progress to make sure it is going to the right place". Continuing, she said:

    "We assess the risk before we commit ourselves to budget support and we audit the use of the funds afterwards. The main assessment is the fiduciary risk assessment, a very detailed investigation and analysis of the public financial management and accountability system of the partner government. It assesses the risk, it makes sure that funds will be used for the intended purposes, that they will be accounted for and that they will achieve value for money. Then we use a whole variety of mechanisms to check on the use of funds during project implementation. We do not just give the money and go away" (Q 1161).

The Minister added that "audits are undertaken by the partner government, international agencies and directly by DFID, including by the UK National Audit Office … We take action if funds are not used properly. In 2007-08 we did reduce budget support to three countries—Sierra Leone, Ghana and Rwanda—because of issues that were related to public financial management and we also delayed budget support to Malawi and Sierra Leone pending receipt of Audit reports"[28]. She concluded by saying that "we only use budget support where there is a commitment by the partner government to reduce poverty, respect human rights, improve their financial management and their good governance" (Q 1161).

181.  We are pleased to hear that the Government is alert to the need to operate effective control mechanisms. In view of this and of the generally favourable comments which have been made to us in the course of our inquiry by IGOs and other organisations concerned with infectious disease control as to the competence and effectiveness of DFID support to developing countries in the health field, we do not believe it appropriate or necessary to make any further observations on the management of UK bilateral aid programmes in this field.

Multilateral Funding

182.  As regards multilateral aid (UK Government funds provided through intergovernmental organisations), securing accountability and value for money is obviously more complex as there are other contributors whose perspectives have to be accommodated as well as our own, and ultimately accountability has to rely on the effectiveness of the control mechanisms of the IGOs themselves. Gillian Merron stated that "we are working hard to improve our assessment of multilateral effectiveness, first of all to provide the evidence that is necessary to have the discussions with multilaterals on their performance and also to inform our own decisions about where we allocate our own aid". She told us that "we are developing a common approach to multilateral effectiveness with ten other donors through a system called MOPAN. We are developing a set of indicators and we will be piloting it at the end of the year". MOPAN (Multilateral Organisations Performance Assessment Network) is a network of like-minded donor countries[29] founded in 2002 following a recognition that it would be more productive to monitor the performance of IGOs collectively rather than individually. MOPAN produces an annual survey looking at multilateral partnership behaviour. Ms Merron drew attention also to the Global Fund's system of performance-based measurement. As an example, she said, "as of December 2007, Global Fund support meant that we had 1.4 million people on ARV treatment, 3.3 million on TB treatment and 46 million insecticide-treated bed nets being distributed. So there are very clear indicators of what is coming out of the efforts rather than just what is going in". Nonetheless there were problems: it was often difficult to attribute overall benefits to individual funding contributions and there was "a need for agencies to be improving the quality of their evaluation and the rigour and consistency with which they are reporting results" (Q 1165).

183.  The Minister of State for Health (Dawn Primarolo) outlined to us an initiative which the UK was taking with WHO in an effort to secure greater accountability. This involved negotiating with WHO mutually-agreed goals and objectives as a basis for providing funding on a more flexible basis than at present. She described this as "a sort of contract agreement with WHO" and "a framework that is transparent for the UK, hopefully a model for others, in terms of accountability of resources" (Q 1168). It seems to us that such a contractual relationship offers the promise of improved accountability by multilateral organisations, especially if pursued by other Member States as well as the UK and if applied not only to WHO but to other IGOs.

184.  We therefore recommend that the initiatives described to us—MOPAN and what might be termed a Service Level Agreement approach—should form the basis for new accountability arrangements between the UK—and, we suggest, other Member States—and IGOs operating in the field of infectious disease control.

A Comprehensive Approach

185.  In 2007 the Government published its proposals for a government-wide Global Health Strategy[30]. In his foreword, the UK Chief Medical Officer spoke of the need for "concerted action on global health and for developing a global health strategy, one that will benefit the health of the UK population and those of the rest of the world". Professor Harper described this initiative as being "very much a cross-Whitehall, cross-agency strategy" whose purpose was "to try to brigade the interests so that we have a more efficient system" (Q 11). He told us:

    "There is a Ministerial group that is chaired by the Minister of State for Public Health, Dawn Primarolo. She chairs a top-level group of Ministers from various Departments, including of course DFID, FCO, Treasury, Ministry of Defence, Defra, what is now DBERR and others—the Devolved Administrations, for example. There is a shadow group of officials who are working to pull together the strategy" (Q 24).

186.  Dawn Primarolo told us that, while the Department of Health (DH) was the lead department for developing the Global Health Strategy, ""it is not only about health and should not only be left to health. It is important that we look for the policy synergies in other departments as well": she instanced DFID and the Foreign and Commonwealth Office (FCO) as having particular interests (QQ 1150-1151). The Minister gave "a very specific assurance to the Committee that our departments—the Department of Health, DFID and the FCO—are working together on the institutional strategy. We are finalising that, and it is the UK's engagement with the World Health Organisation, which of course the Department of Health takes the lead on" (Q 1144).

187.  While we applaud the initiative which the Government is taking in developing a Global Health Strategy, we would place a question mark over whether the lead should necessarily lie with DH. The answer to this question depends, to a large extent, on what the strategy is meant to achieve. Though the Minister suggested to us that it was "about how the whole of government should be interacting and working with the WHO", the Government's Health is Global report takes a rather wider view, including international development and interaction with a range of IGOs. There is no doubt that, with its responsibility for formulating health policy for this country and for representing the UK at the WHO, DH is a substantial stakeholder in the Strategy. However, it is arguable that, from the point of view of global infectious disease control, others are equally, if not more, heavily engaged. DFID, as will be apparent from Table 1, provides the lion's share of UK funding for international disease control and is the department with staff working on the ground in developing countries. Indeed, we have been struck during our inquiry by the de facto lead which DFID has assumed in providing evidence and answering our questions. FCO too has a considerable stake in an area of activity which is increasingly becoming focused on the conduct of relations with other countries and with intergovernmental organisations. At a recent symposium in Geneva on "Foreign Policy and Global Health", Dr Margaret Chan, Director-General of WHO, called for health "to be given a high priority in foreign policy" and for health to be regarded as "a worthy area for foreign diplomacy"[31].

188.  Switzerland has recently given serious consideration to this question of how health policy can best be nationally coordinated in an era when health management is becoming increasingly subject to external drivers. Like the UK, Switzerland has its Health, International Development and Foreign Ministries[32]. Dr Silberschmidt, of the Swiss Federal Office of Public Health (SFOPH), told us:

    "I have had exchanges with many colleagues from other industrialised countries and the tension we most often have is that the Minister of Health is in the lead in the WHO, whereas the Ministry of Development has most resources and is paying most money to WHO. All the time there is the question as to who is really the decision-maker" (Q 588).

This has led the Swiss to develop the concept of a 'Health Foreign Policy', in which the Federal Department of Foreign Affairs (in Dr Silberschmidt's words) acts as broker between the Health and Development Ministries. It has also involved the creation, within the Swiss Federal Department of Foreign Affairs, of a Coordinating Office which is "the contact point for all relevant enquiries from the FOPH and other offices of the federal administration" and which "ensures the coherence of health foreign policy as part of overall Swiss foreign policy"[33].

189.  We do not suggest that the UK should simply replicate the Swiss arrangements. Nor do we have a ready-made solution to the problem to offer. We do, however, recommend that the Government should take another look at the machinery for coordinating UK policies with a view to ensuring that the interests of those Whitehall departments who are closely involved with the international dimension of global health are given their due weight and that this is reflected in the arrangements for leadership of the Global Health Strategy.


27   See Q 27 Back

28   In the time available we were unable to examine the audit reports referred to, but we have asked the Department to place copies in the Library. Back

29   Current members are Austria, Canada, Denmark, Finland, France, Ireland, The Netherlands, Norway, Sweden, Switzerland and the UK. Back

30   "Health is Global", Department of Health, 2007 Back

31   Symposium "Foreign Policy and Global Health: working together towards common goals", 13 June 2008 Back

32   The Swiss Federal Office of Public Health, the Swiss Agency for Development and Cooperation, and the Swiss Federal Department of Foreign Affairs, respectively. Back

33   "Swiss Health Foreign Policy", Page 18 Back


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008